Results 201 to 210 of about 4,730,461 (228)

Strategies for integrating artificial intelligence and cognitive assessment to predict disability progression in relapsing-remitting multiple sclerosis: A model development study. [PDF]

PLOS Digit Health
Zhu C, Zhang X, van der Walt A, Taylor B, Monif M, Kalincik T, Lechner-Scott J, Buzzard K, Kilpatrick T, Barnett M, Zhou Z, Jokubaitis V, Gresle M, Darby D, Mehta D, Ge Z, Butzkueven H, Merlo D.   +17 more
europepmc   +1 more source

Associations Between Neuromuscular Fatigue, Anxiety, and Peripheral Biomarkers of Neuronal Injury, Inflammation, and Mitochondrial Dysfunction in Treatment-Naïve Relapsing-Remitting Multiple Sclerosis. [PDF]

Brain Behav
Steckert AV, Feltrin KD, Rodrigues LFS, Liz FM, Muller MMF, Bortoluzzi DP, Mayer AB, Ceretta LB, Barichello T, Dal-Pizzol F, Dominguini D.   +10 more
europepmc   +1 more source

Identification of diagnostic biomarkers for relapsing-remitting multiple sclerosis in plasma by mass spectrometry-based proteomics. [PDF]

J Neuropathol Exp Neurol
García-Silva VM, Chicano-Galvez E, García-Sánchez MI, Peralbo-Molina Á, Hernández-Valladares M.   +4 more
europepmc   +1 more source

Regional IVIM-DWI Abnormalities in Normal-Appearing White Matter and Lesion Tissue in Relapsing-Remitting Multiple Sclerosis. [PDF]

J Clin Med
Alomair OI, Alghamdi SA.
europepmc   +1 more source

Effectiveness and Safety of Rituximab in Filipino Patients With Relapsing-Remitting Multiple Sclerosis: A Real-World Retrospective Cohort Study in a Resource-Limited Setting. [PDF]

Cureus
Co APC, De la Paz FGE, Aninang MT, Del Mundo MES, Nobleza CMN, Damian LF.   +5 more
europepmc   +1 more source

Longitudinal Stability of the Gut Microbiota in Relapsing-Remitting Multiple Sclerosis: A Prospective Observational Study. [PDF]

Microorganisms
Vacaras C, Vacaras V, Nistor C, Jucan C, Furdui IM, Vesa SC, Strilciuc S, Ștefănescu E, Chira D, Rafila A, Muresanu DF.   +10 more
europepmc   +1 more source

Risk factors for relapse in relapsing remitting multiple sclerosis [PDF]

British Journal of Neuroscience Nursing, 2021
Relapsing remitting is the most common type of multiple sclerosis, affecting approximately 85% of all patients. Previous evidence has suggested that the risk factors for developing relapsing remitting multiple sclerosis is multifactorial.
James Hill, Karen Palmer
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Quantitative magnetization transfer imaging in relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.

Brain Communications, 2022
Michael Jonathan Thrippleton, Elizabeth York, Rozanna Meijboom   +2 more
exaly